Biomerieux SA
PAR:BIM

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
PAR:BIM
Watchlist
Price: 122 EUR 1.24% Market Closed
Market Cap: 14.4B EUR

Wall Street
Price Targets

BIM Price Targets Summary
Biomerieux SA

Wall Street analysts forecast BIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIM is 127.5 EUR with a low forecast of 90.9 EUR and a high forecast of 147 EUR.

Lowest
Price Target
90.9 EUR
25% Downside
Average
Price Target
127.5 EUR
5% Upside
Highest
Price Target
147 EUR
20% Upside
Biomerieux SA Competitors:
Price Targets
338220
Vuno Inc
91% Upside
688271
Shanghai United Imaging Healthcare Co Ltd
23% Upside
INMD
Inmode Ltd
24% Upside
4543
Terumo Corp
28% Upside
NNOX
Nano-X Imaging Ltd
84% Upside
CLPT
Clearpoint Neuro Inc
112% Upside
ANGO
AngioDynamics Inc
44% Upside
MYO
Myomo Inc
210% Upside

Revenue
Forecast

Revenue Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's revenue is 8%. The projected CAGR for the next 3 years is 8%.

8%
Past Growth
8%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's operating income is 11%. The projected CAGR for the next 3 years is 13%.

11%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

12%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIM's stock price target?
Price Target
127.5 EUR

According to Wall Street analysts, the average 1-year price target for BIM is 127.5 EUR with a low forecast of 90.9 EUR and a high forecast of 147 EUR.

What is Biomerieux SA's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Biomerieux SA's revenue is 8%. The projected CAGR for the next 3 years is 8%.

What is Biomerieux SA's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Biomerieux SA's operating income is 11%. The projected CAGR for the next 3 years is 13%.

What is Biomerieux SA's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Biomerieux SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

Back to Top